Traffic Roots Audience Pixel

Post categorized under: PDx News & Insights

PDx News & Insights

PathogenDx delivers viral testing solutions for a new era dominated by the global pandemic, and is at the forefront of cannabis, and food testing. We are answering the challenge of individuals, communities and the moment itself, while monitoring the global conversation around pathogen testing to offer even more powerful solutions. Catch up on the latest news driving the future of safe.

  • PathogenDx honored by Fast Company’s 2022 World Changing Ideas Awards

    The winners of Fast Company’s 2022 World Changing Ideas Awards were announced, and PathogenDx has been honoured for work in Clinical diagnostics. DetectX-Cv has detected all major Clade Variants, providing results in four hours after receiving a positive sample from any COVID-19 test, running up to 576 samples in a single shift for a fraction of the cost of NGS Sequencing.

    Read more »

  • The Need for More Stringent Cannabis Lab Testing by PathogenDx Co-Founder and CEO Milan Patel

    Patel shares insights on the current state of microbal Cannabis testing in the U.S., where we’re falling short, and how we can right the trajectory of the industry by establishing better Cannabis lab testing procedures.

    Read insights »

  • Talking Hedge Podcast: Cannabis Lab Testing with PathogenDx’s Milan Patel

    CEO Milan Patel PathogenDx talks the development of diagnostic solutions to address viral, bacterial and fungal infection or contamination of Cannabis. Patel digs deep into meeting Cannabis state regulations, Cannabis lab testing efficiency, hemp mold testing, hop latent virus, and preventative pathogen testing.

    Watch the discussion »

  • PathogenDx Strengthens Executive Team; Announces Several New Key Leadership Appointments

    PathogenDx is pleased to announce the addition of Board Advisor Paul Glyer, Vice President of Research and Development Ralph Martel, Food & Agriculture Board Advisor Michael Drozd, PhD, and Global Director of Sales Carol Dugas.

    “These highly experienced individuals will help us navigate both strategically and tactically as we expand across the different vertical markets with our next-generation diagnostic testing technologies.” – Co-founder and CEO Milan Patel.

    Read full article »

  • Lit & Lucid Episode 149 – Creating Efficiency With Cannabis Pathogen Testing with Milan Patel, Co-Founder & CEO of PathogenDx

    PathogenDx Co-founder and CEO Milan Patel stopped by the Lit & Lucid Podcast to discuss the ease of testing Cannabis crops and the importance of testing in regards to consumer safety. The group spoke in lengths about the present and future of Cannabis pathogen testing technology and how PathogenDx separates itself from others on the market.

    Listen here »

  • BOFC Live E.396: Fast Cannabis Testing Capabilities Helping the Sector Right Now

    Co-Founder and CEO Milan Patel connects to talk about PathogenDx, the unique processes we utilize for cannabis lab and in-grow environmental testing as well as the path forward to testing in the United States.

    Read full article »

  • Arizona Companies PathogenDx, Formula Diagnostics and Bashas’ Food City Offer Safe, Accurate and Fast COVID-19 Testing to Uninsured Arizonans

    PathogenDx, Formula Diagnostics (“FDX”), a provider of clinical laboratories and health services, and Bashas’ Food City, a family-owned-and-operated grocer, announced a community service partnership, which is bringing uninsured individuals in Phoenix and Mesa access to COVID-19 testing at no cost. The Arizona-based companies will be dedicating time and volunteering resources to deliver safe, accurate and fast tests, with results available within 24 to 48 hours.

    More here »

  • PathogenDx CEO Milan Patel Calls on President Joe Biden to Implement Newest State of the Art Diagnostic Technologies in Global Battle against COVID-19 Variants

    While the FDA is considering Emergency Use Authorization submissions for SARS-CoV-2 variant genotyping assays, PathogenDx co-founder and CEO Milan Patel issued the following letter to U.S. President Joe Biden, urging him to implement state of the art diagnostic technologies in the battle against the COVID-19 pandemic.

    Read letter »

  • CEO Milan Patel Speaks on Recent Trends in Cannabis and Hemp Testing

    “We’ve seen the USDA weigh in on hemp, and that is the first signal of what the future could look like. Given the unique position cannabis sits in with respect to a plant that has medicinal values, can be sold as edibles (food), and as supplementals, the regulatory framework cuts across major agencies and will take some time to unfold.”

    More here »

  • PathogenDx, Axiology Labs Ink Deal to Distribute Detectx-Cv Assay Across Africa and Thailand

    Axiology Labs will distribute PathogenDx’s Detectx-Cv Clade Variant equipment and testing kits to its lab network across Africa and Thailand. Axiology Labs will install, train, support, and service its locations across these markets in identifying SARS-CoV-2 variants.

    Read more »